CWM
MRNA icon

CIBC World Markets’s Moderna MRNA Stock Holding History

CIBC World Markets’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.07M Buy
+36,304
New +$986K 0.01% 722
2025
Q2 		$791K Sell
28,652
-11,669
-29% -$307K 0.01% 706
2025
Q1 		$1.14M Sell
40,321
-12,565
-24% -$446K 0.01% 646
2024
Q4 		$2.2M Sell
52,886
-687
-1% -$32.8K 0.01% 528
2024
Q3 		$3.58M Sell
53,573
-16,709
-24% -$1.53M 0.03% 397
2024
Q2 		$8.35M Buy
70,282
+12,166
+21% +$1.54M 0.05% 227
2024
Q1 		$6.19M Sell
58,116
-39,095
-40% -$3.94M 0.04% 278
2023
Q4 		$9.67M Buy
97,211
+35,154
+57% +$2.96M 0.05% 243
2023
Q3 		$6.41M Sell
62,057
-8,294
-12% -$925K 0.06% 201
2023
Q2 		$8.55M Buy
70,351
+49,007
+230% +$6.54M 0.07% 190
2023
Q1 		$3.28M Sell
21,344
-22,067
-51% -$3.64M 0.05% 255
2022
Q4 		$7.8M Buy
43,411
+38,306
+750% +$6.26M 0.05% 242
2022
Q3 		$604K Sell
5,105
-41,215
-89% -$6.25M 0.01% 417
2022
Q2 		$6.62M Sell
46,320
-37,910
-45% -$5.42M 0.06% 185
2022
Q1 		$14.5M Buy
84,230
+8,835
+12% +$1.49M 0.11% 131
2021
Q4 		$19.1M Sell
75,395
-19,755
-21% -$5.78M 0.1% 124
2021
Q3 		$36.6M Buy
95,150
+90,799
+2,087% +$33.5M 0.25% 76
2021
Q2 		$1.02M Sell
4,351
-10,945
-72% -$1.96M 0.01% 533
2021
Q1 		$2M Sell
15,296
-20,081
-57% -$2.91M 0.01% 442
2020
Q4 		$3.7M Buy
35,377
+13,428
+61% +$1.36M 0.02% 420
2020
Q3 		$1.55M Buy
+21,949
New +$1.53M 0.02% 469

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

CIBC World Markets's MRNA Position: Q4 2025 in Review

CIBC World Markets opened a new position in Moderna (MRNA) in Q4 2025: 36,304 shares worth $1.07M. The stake represents 0.01% of the portfolio and ranks #722 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in MRNA as recently as Q2 2025.

CIBC World Markets first reported a position in MRNA in Q3 2020 and has held it in 21 quarters since. The position peaked at $36.6M in Q3 2021. 672 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • CIBC World Markets held 36,304 shares of Moderna worth $1.07M as of Q4 2025.
  • Moderna was a new CIBC World Markets position in Q4 2025.
  • Moderna made up 0.01% of CIBC World Markets's portfolio in Q4 2025, its #722 holding.
  • CIBC World Markets first reported a position in Moderna in Q3 2020 and has held it in 21 quarters since.
  • CIBC World Markets's Moderna position peaked at $36.6M in Q3 2021.
  • 672 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.